Clear Street’s Pfizer PFE Stock Holding History

Clear Street’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-250,000	Closed	-$9.17M	–	1249
2023 Q2	$9.17M	Buy	+250,000	New	+$9.73M	0.09%	145
2022 Q4	–	Sell	-113,600	Closed	-$4.97M	–	1132
2022 Q3	$4.97M	Buy	+113,600	New	+$5.52M	0.12%	86

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clear Street's PFE Position: Q3 2023 in Review

Clear Street sold out of Pfizer (PFE) in Q3 2023, closing a stake of 250,000 shares — an estimated $9.17M sold.

Clear Street first reported a position in PFE in Q3 2022 and held it in 2 quarters. The position peaked at $9.17M in Q2 2023. 2,926 funds tracked by Wall St. Rank hold PFE as of Q3 2023.

Clear Street reported no remaining Pfizer position as of Q3 2023 after selling out during the quarter.
Clear Street sold 250,000 Pfizer shares in Q3 2023, an estimated $9.17M.
Clear Street first reported a position in Pfizer in Q3 2022 and held it in 2 quarters.
Clear Street's Pfizer position peaked at $9.17M in Q2 2023.
2,926 funds tracked by Wall St. Rank held Pfizer as of Q3 2023.

Based on Clear Street's 13F filing for Q3 2023, filed 13 Nov 2023.